Intervention not reported
Leg pain, long term Visual analogue scale (VAS 0 to 100) · participants with lumbar spinal stenosis
1 finding from 1 review
no estimate extracted
373 participants
Moderate
Intervention not reported
Low back pain, long term Visual analogue scale (VAS 0 to 100) · participants with lumbar spinal stenosis
1 finding from 1 review
no estimate extracted
373 participants
Moderate
Intervention not reported
General health, long term Visual analogue scale (VAS 100 to 0) · participants with lumbar spinal stenosis
1 finding from 1 review
no estimate extracted
273 participants
Low
Mortality within the longest · surgical patients
Protocol to increase global blood flow showed no clear difference in mortality (Longest compared with control (low certainty).
1 finding from 1 review
Mortality (Hospital or 28‐day) · surgical patients
Protocol to increase global blood flow showed no clear difference in mortality (Hospital or 28‐day) compared with control (low certainty).
1 finding from 1 review
Number of patients with complications · surgical patients
Protocol to increase global blood flow may leads to lower number of patients with complications compared with control (low certainty).
1 finding from 1 review
Length of hospital stay · surgical patients
1 finding from 1 review
Change in sensory score after one year · patients with nerve damage in leprosy
1 finding from 1 review
Proportion of ulnar nerves with sensory improvement after one year · patients with nerve damage in leprosy
It is very uncertain whether medial epicondylectomy plus oral steroids changes proportion of ulnar nerves with sensory improvement after one year compared with oral steroids alone (very low certainty).
1 finding from 1 review
Change in motor score after one year · patients with nerve damage in leprosy
1 finding from 1 review
Proportion of ulnar nerves with motor improvement after one year · patients with nerve damage in leprosy
It is very uncertain whether medial epicondylectomy plus oral steroids changes proportion of ulnar nerves with motor improvement after one year compared with oral steroids alone (very low certainty).
1 finding from 1 review
Change in sensory score after two years · patients with nerve damage in leprosy
1 finding from 1 review
Change in motor score after two years · patients with nerve damage in leprosy
1 finding from 1 review
Intervention not reported
Death within 5 years · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in death within 5 years (moderate certainty).
1 finding from 1 review
Intervention not reported
Disease progression within 5 years · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention probably leads to lower disease progression within 5 years (moderate certainty).
1 finding from 1 review
Intervention not reported
Haematological adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in haematological adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
Intervention not reported
Gastrointestinal adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in gastrointestinal adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
Intervention not reported
Genitourinary adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in genitourinary adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
Intervention not reported
Pain ‐ not measured · patients with chronic (>12 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Adverse events ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review